The impact of obesity in urology

Urologic Clinics of North America

Volumn 31, Issue 2, 2004, Pages 275-287

  Mydlo, Jack H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; SELENIUM; VITAMIN D;

BLADDER CANCER; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; ERECTILE DYSFUNCTION; EXERCISE; FEMALE FERTILITY; HUMAN; INCIDENCE; KIDNEY CANCER; KIDNEY DISEASE; LOW FAT DIET; MALE FERTILITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; STONE FORMATION; STRESS INCONTINENCE; TESTIS CANCER; URINARY TRACT CANCER; URINARY TRACT DISEASE; WEIGHT REDUCTION;

AGE DISTRIBUTION; BODY MASS INDEX; COMORBIDITY; FEMALE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; OBESITY; PREVALENCE; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; UNITED STATES; UROLOGIC DISEASES; UROLOGIC NEOPLASMS;

EID: 2342595214     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2004.01.005     Document Type: Review

References (118)

1. Wolf A.M., Colditz G.A. Current estimates of the economic cost of obesity in United States. Obes Res. 6:1998;97-106
2. Mitka M. Economist takes aim at "big fat" US lifestyle. JAMA. 289:(1):2003;33-34
3. Flegal K.M., Carroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: prevalence and trends 1960-1994. Int J Obesity. 22:1998;39-47
4. Rosenbaum M., Leibel R.L., Hirsch J. Obesity. N Engl J Med. 337:(6):1997;396-407
5. Najjar M.F., Rowland M. National Center for Health Statististics. Anthropometric reference data and prevalence of overweight, United States. 1976-80. Vital and Health Stat. 11:1987;238
6. Kiess W., Galler A., Reich A., Muller G., Kapallen T., Deutscher J., et al. Clinical aspects of obesity in childhood and adolescence. Obes Rev. 2:(1):2001;29-36
7. James W.P., Ralph A. New understanding in obesity research. Proc Nutr Soc. 58:(2):1999;385-393
8. Demark-Wahnefried W., Conaway M.R., Robertson C.N., Mathias B.J., Anderson E.E., Paulson D.F. Anthropometric risk factors for prostate cancer. Nutr Cancer. 28:(3):1997;302-307
9. Sobal J., Stunkard A.J. Socioeconomic status and obesity: a review of the literature. Psychol Bull. 105:1989;260-275
10. Rodin J. Cultural and psychosocial determinants of weight concerns. Ann Intern Med. 119:1993;643-645
11. Brownell K.D., Fairburn C.G. Eating disorders and obesity: a comprehensive handbook. 1995;Guilford Press, New York
12. Van Itallie T. Health implications of overweight and obesity in the United States. Ann Intern Med. 103:1985;983-988
13. Dallosso H.M., McGrother C.W., Matthews R.J., Donaldson M.M. Leicestershire MRC Incontinence Study Group: the association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int. 92:(1):2003;69-77
14. Cummings J.M., Rodning C.B. Urinary stress incontinence among obese women: review of pathophysiology therapy. Int Urogynecol J Pelvic Floor Dysfunct. 11:(1):2000;41-44
15. Bai S.W., Kang J.Y., Rha K.H., Lee M.S., Kim J.Y., Park K.H. Relationship of urodynamic parameters and obesity in women with stress urinary incontinence. J Reprod Med. 47:(7):2002;559-563
16. Haidinger G., Temml C., Schatzl G., Brossner C., Roehlich M., Schmidbauer C.P., et al. Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol. 37:(4):2000;413-420
17. Soygur T., Kupeli B., Aydos Kupeli S., Arikan N., Muftuoglu Y.Z. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol. 28:(1):1996;55-59
18. Dahle S.E., Chokkalingam A.P., Gao Y.T., Deng J., Stanczyk F.Z., Hsing A.W. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol. 168:(2):2002;599-604
19. Hammarsten J., Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press. 8:(1):1999;29-36
20. Hammarsten J., Hogstedt B. Calculated fast-growing benign prostatic hyperplasia - a risk factor for developing clinical prostate cancer. Scand J Urol Nephrol. 36:(5):2002;330-338
21. Irani J., Lefebvre O., Murat F., Dahmani L., Dore B. Obesity in relation to prostate cancer risk: comparison with a population having benign prostatic hyperplasia. BJU Int. 91:(6):2003;482-484
22. Cohen P.G. Aromatase, adiposity, aging and disease: The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses. 56:(6):2001;702-708
23. Chung W.S., Sohn J.H., Park Y.Y. Is obesity an underlying factor in erectile dysfunction? Eur Urol. 36:(1):1999;68-70
24. Boyanov M.A., Boneva Z., Christov V.G. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 6:(1):2003;1-7
25. Alter G.J., Ehrlich R.M. A new technique for correction of the hidden penis in children and adults. J Urol. 161:(2):1999;455-459
26. Jung A., Schill W.B. Male infertility: current lifestyle could be responsible. MMW Fortschr Med. 142:(37):2000;31-33
27. Norman R.J., Clark A.M. Obesity and reproductive disorders: a review. Reprod Fertil Dev. 10:(1):1998;55-63
28. Crosignani P.G., Vegetti W., Colombo M., Ragni G. Resumption of fertility with diet in overweight women. Reprod Biomed Online. 5:(1):2002;60-64
29. Foreyt J.P., Poston W.S. Obesity: a never ending cycle? Int J Fertil Womens Med. 43:(2):1998;111-116
30. Powell C.R., Stoller M.L., Schwartz B.F., Kane C., Gentile D.L., Bruce J.E., et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 55:(6):2000;825-830
31. Delakas D., Karyotis I., Daskalopoulos G., Lianos E., Mavromanolakis E. Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second generation lithotripter. J Endourol. 17:(4):2003;201-205
32. Dash A., Schuster T.G., Hollenbeck B.K., Faerber G.J., Wolf J.S. Jr. Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison. Urology. 60:(3):2002;393-397
33. Kakaim A.G., Badgett D., Carpinito G., Mesler D., Idelson B., Liberthal W. Ideal body weight predicts remaining renal function following donor nephrectomy. Transplant Proc. 29:(7):1997;2781-2782
34. Praga M., Hernandez E., Herrero J.C., Morales E., Revilla Y., Diaz-Gonzalez R., et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 58:(5):2000;2111-2118
35. Cumin F., Baum H.P., de Gasparo M., Levens N. Removal of endogenous leptin from the circulation by the kidney. Int J Obes Relat Metab Disord. 21:(6):1997;495-504
36. Roe F.J. Food and cancer. J Hum Nutr. 33:(6):1979;405-415
37. Trichopoulos D., Li F.P., Hunter D.J. What causes cancer? Sci Am. 275:(3):1996;80-87
38. Chandra R.K. Graying of the immune system. JAMA. 277:(17):1997;1398-1399
39. Yancopoulos G.D., Klagsbrun M., Folkman J. Vasculogenesis, angiogenesis, and growth factors. Cell. 93:(5):1998;741-753
40. Mydlo J.H., Bulbul M.A., Richon V.M., Heston W.D.W., Fair W.R. Heparin-binding growth factor isolated from human prostatic extracts. Prostate. 12:1988;343-355
41. Mydlo J.H., Heston W.D.W., Fair W.R. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney. J Urol. 140:1988;1575-1579
42. Mydlo J.H., Kral J.G., Macchia R.J. Differences in prostate and adipose tissue basic fibroblast growth factor: an analysis of preliminary results. Urology. 50:(3):1997;472-478
43. Mydlo J.H., Kral J.G., Macchia R.J. Preliminary results comparing the recovery of basic fibroblast growth factor (FGF-2) in adipose, benign and malignant renal tissue. J Urol. 159:1998;2159-2163
44. Weber R.V., Stein D.E., Scholes J., Kral J.G. The role of obesity vs high fat diet in rat colon cancer. Proc Am Assoc Cancer Res. 39:1998;813
45. Mydlo J.H., Gerstein M.I., Harris C.F., Braverman A.S. Immunity, angiogenic growth factor activity, and mitogenicity in obese and lean rodent sera: implications in obesity related prostate tumor biology. Prostate Cancer Prostatic Dis. 6:2003;286-289
46. Mydlo J.H., Tieng N., Volpe M.A., Chaiken R., Kral J.G. A pilot study of serum testosterone, diet and body mass index in African-American and caucasian men with and without prostate cancer. Prostate Cancer Prostatic Dis. 4:2001;1-5
47. Nguyen M., Watanabe H., Budson A.E., Richie J.P., Hayes D.F., Folkman J. Elevated levels of an angiogenic peptide bFGF in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 86:1994;356-364
48. Cohen P., Peehl D.M., Stamey T.A., Wilson K.F., Clemmons D.R., Rosenfeld R.G. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 76:(4):1993;1031- 1036
49. Deslypere J.P., Verdonck L., Vermeulen A. Fat tissue: a steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab. 61:(3):1985;564-570
50. Erickson K.L., Hubbard N.E. A possible mechanism by which dietary fat can alter tumorigenesis: lipid modulation of macrophage function. Adv Exp Med Biol. 364:1994;67-81
51. Miller A.B., Berrino F., Hill M., Pietinen P., Riboli E., Wahrendorf J. Diet in the etiology of cancer: a review. Eur J Cancer. 30A:(2):1994;133-146
52. Hietanen E., Bartsch H., Bereziat J.C., Camus A.M., et al. Diet and oxidative stress in breast, colon and prostate cancer patients: a case control study. Eur J Nutr. 48:(8):1994;575-586
53. Saglam K., Aydur E., Yilmaz M., Goktas S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol. 169:(4):2003;1308- 1311
54. Gettys T.W., Harkness P.J., Watson P.M. The beta 3-adrenergic receptor inhibits insulin stimulated leptin secretion from isolated rat adipocytes. Endrocinology. 137:1996;4054-4057
55. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med. 334:1996;292-295
56. Sierra-Honigman M.R., Nath A.K., Murakami C., et al. Biologic action of leptin as an angiogenic factor. Science. 281:1998;1683-1686
57. Kropiunigg U. Basics in psychoneuroimmunology. Ann Med. 25:(5):1993;473-479
58. Cohen S., Manuck S.B. Stress, reactivity and disease. Psychosom Med. 57:(5):1995;423-426
59. Stein M. Stress, depression and the immune system. J Clin Psychol. 50:1989;35-40
60. Pienta K.J., Esper P.S. Risk factors for prostate cancer. Ann Intern Med. 118:(10):1993;793-803
61. Greenwald P., Kramer B., Weed D. Expanding horizons in breast and prostate cancer prevention and early detection. The 1992 Samuel C. Harvey Lecture. J Cancer Educ. 8:(2):1993;91-107
62. McGuire M.S., Fair W.R. Prostate cancer and diet: investigations, interventions, and future considerations. Mol Urol. 1:1997;3-9
63. Andersson S.O., Wolk A., Bergstrom R., Giovannucci E., Lindgren C., Baron J., et al. Energy, nutrient intake and prostate cancer risk: a population-based case control study in Sweden. Int J Cancer. 68:(6):1996;716-722
64. Rohan T.E., Howe G.R., Burch J.D., Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control. 6:(2):1995;145-153
65. Giovannucci E. How is individual risk for prostate cancer assessed? Hematol Oncol Clin North Amer. 10:(3):1996;537-548
66. Giovannucci E., Ascherio A., Rimm E.B., Stampfer M.J., Colditz G.A., Willet W.C. Intake of carotenoids and retinoids in relation to risk of prostate cancer. J Natl Cancer Inst. 87:1995;1767-1776
67. Amling C.L., Kane C.J., Riffenburgh R.H., Ward J.F., Roberts J.L., Lance R.S., et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology. 58:(5):2001;723-728
68. Rohrmann S., Roberts W.W., Walsh P.C., Platz E.A. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate. 55:(2):2003;140-146
69. Mellemgaard A., McLaughlin J.K., Overvad K., Olsen J.H. Dietary risk factors for renal cell carcinoma in Denmark. Eur J Cancer. 32A:(4):1996;673-682
70. Kreiger N., Marrett L.D., Dodds L., Hilditch S., Darlington G.A. Risk factors for renal cell carcinoma: results of a population based case-control study. Cancer Causes Control. 4:(2):1993;101-110
71. Lindblad P., Wolk A., Bergstrom R., Persson I., Adami H.O. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 3:(8):1994;631-639
72. Wolk A., Gridley G., Niwa S., Lindblad P., McCredie M., Mellemgaard A., et al. International renal cell cancer study: the role of diet. Int J Cancer. 65:(1):1996;67-73
73. Chow W.H., Gridley G., McLaughlin J.K., Mandel J.S., Wacholder S., Blot W.J., et al. Protein intake and risk of renal cell cancer. J Natl Cancer Inst. 86:1994;1131-1139
74. Moyad M.A. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol. 19:(4):2001;270-279
75. Boeing H., Schlehofer B., Wahrendorf J. Diet, obesity and risk for renal cell carcinoma: results from a case control-study in Germany. Z Ernahrungswiss. 36:(1):1997;3-11
76. Yuan J.M., Castelo J.E., Gago-Dominguez M., Ross R.K., Yu M.C. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer. 77:(9):1998;1508-1513
77. Chow W.H., Gridley G., Fraumeni J.J., Jarvholm B. Obesity, hypertension and the risk of kidney cancer in men. N Engl J Med. 343:(18):2000;1305-1311
78. Gago-Dominguez M., Castelao J.E., Yuan J.M., Ross R.K., Yu M.C. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell cancer. Cancer Causes Control. 13:(3):2002;287-293
79. Bergstrom A., Hsieh C.C., Lindblad P., Lu C.M., Cook N.R., Wolk A. Obesity and renal cell cancer - a quantitative review. Br J Cancer. 85:(7):2001;984-990
80. Calatayud Sarthou A., Cortes Vizcaino C., Talamante Serrula S., Corella Piquer D. Descriptive epidemiologic study of 514 cases of bladder cases. Arch Esp Urol. 47:(6):1994;574-579
81. Glickman L.T., Schofer F.S., McKee L.J., Reif J.S., Goldschmidt M.H. Epidemiologic study of insecticide exposures, obesity and risk of bladder cancer in household dogs. J Toxicol Environ Health. 28:(4):1989;407-414
82. Vena J.E., Graham S., Freudenheim J., Marshall J., Zielezny M., Swanson M., et al. Diet in the epidemiology of bladder cancer in western New York. Nutr Cancer. 18:(3):1992;255-264
83. Bruemmer B., White E., Vaughan T.L., Cheney C.L. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol. 144:(5):1996;485-495
84. Shirai T., Fradet Y., Huland H., Bollack C., Droller M., Janknegi R., et al. The etiology of bladder cancer - are there any new clues or predictors of behavior? Int J Urol. 2:1995;64-76
85. Pirastu R., Iavarone I., Comba P. Bladder cancer: a selected review of the epidemiological literature. Ann Ist Super Sanita. 32:(1):1996;3-20
86. La Vecchia C., Negri E. Nutrition and bladder cancer. Cancer Causes Control. 7:(1):1996;95-100
87. De Stefani E., Fierro L., Barrios E., Ronco A. Tobacco, alcohol, diet and risk of prostate cancer. Tumori. 81:(5):1995;315-320
88. Rogers A.E., Zeisel S.H., Groopman J. Diet and carcinogenesis. Carcinogenesis. 14:(11):1993;2205-2217
89. Davies T.W., Prener A., Engholm G. Body size and cancer of the testis. Acta Oncol (Madr). 29:(3):1990;287-290
90. Kolonel L.N., Ross R.K., Thomas D.B., Thompson D.J. Epidemiology of testicular cancer in the Pacific Basin. J Natl Cancer Inst Monogr. 62:1982;157-160
91. Jones K. Can the morbidly obese have the same "standard of care?" Anesth Analg. 97:(2):2003;603
92. El-Feel A., Davis J.W., Deger S., Roigas J., Wille A.H., Schnorr D., et al. Laparoscopic radical prostatectomy - an analysis of factors affecting operating time. Urology. 62:(2):2003;314-318
93. Kamerer A., Basler J., Thompson I. Novel technique of vest suture vesicourethral anastomosis in morbidly obese patient undergoing radical retropubic prostatectomy. J Urol. 170:(1):2003;174-177
94. Fazeli-Matin S., Gill I.S., Hsu T.H., Sung G.T., Novick A.C. Laparoscopic renal and adrenal surgery in obese patients: comparison to open surgery. J Urol. 162:(3 part 1):1999;665-669
95. Jacobs S.C., Cho E., Dunkin B.J., Bartlett S.T., Flowers J.L., Jarrell B., et al. Laparoscopic nephrectomy in the markedly obese living renal donor. Urology. 56:(6):2000;926-929
96. Mansfield J.T., Stephenson R.A. Does transurethral resection of the prostate compromise the radical treatment of prostate cancer? Semin Urol Oncol. 14:(3):1996;174-177
97. Oefelein M.G., Kaul K., Herz B., Blum M.D., Holland U.M., Keeler T.C. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol. 155:(1):1996;238-242
98. Thompson H.J., Zhu Z., Jiang W. Dietary restriction in breast cancer prevention. J Mammary Gland Biol Neoplasia. 8:(1):2003;133-142
99. De Vries C.E., van Noorden C.J. Effects of dietary fatty acid composition on tumor growth and metastasis. Anticancer Res. 12:(5):1992;1513-1522
100. Wang Y., Corr J.G., Thaler H.T., Tao Y., Fair W.R., Heston W.D.W. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low fat diet. J Natl Cancer Inst. 87:(19):1995;1456-1467
101. Fair W.R., Fleshner N.E., Heston W.D.W. Cancer of the prostate: a nutritional disease? Urology. 50:(6):1997;840-848
102. Wang Y., Heston W.D.W., Fair W.R. Soy isoflavones decrease the high fat promoted growth of human prostate cancer: results of in vitro and animal studies. Proc Am Urol Assoc. 153:1995;269A
103. Lee E.S., Steiner M., Lin R. Thioallyl compounds: potent inhibitors of cell proliferation. Biochem Biophys Acta. 1221:1994;73-77
104. Clark L.C., Combs D.F. Jr., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA. 276:1996;1957-1964
105. The Alpha-Tocoferol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and betacarotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 330:1994;1029-1035
106. Klein E.A., Thompson I.M., Lippman S.M., Goodman P.J., Albanes D., Taylor P.R., et al. SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol. 21:(1):2003;59-65
107. Daviglus M.L., Dyer A.R., Persky V., Chavez N., Drum M., Goldberg J., et al. Dietary beta-carotene, vitamin C, and the risk of prostate cancer: results from the Western Electric Study. Epidemiology. 7:(5):1996;472-477
108. Schwartz G.G., Hill C.C., Oeler T.A., Becich M., Bahnson R.R. 1, 25-Dihydroxy-16-ene-23-ync-vitamin D3 and prostate cell proliferation in vivo. Urology. 46:1995;365-369
109. Corder E.H., Guess H.A., Hulka B.S., Friedman G.B., Sadler M., Vollmer R.T., et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev. 2:1993;467-472
110. Shephard R.J. Exercise and cancer: linkages with obesity? Int J Obes Relat Metab Disord. 19:(suppl 4):1995;562-568
111. Shephard R.J. Physical activity and reduction of health risks: how far are the benefits independent of fat loss? J Sports Med Phys Fitness. 34:(1):1994;91-98
112. Whittemore A.S., Kolonel L.N., Wu A.H., John E.M., Gallagher R.P., Howe G.R., et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 87:(9):1995;652-662
113. Moller H., Mellemgaard A., Lindvig K., Olsen J.H. Obesity and cancer risk: A Danish record-linkage study. Eur J Cancer. 30A:1994;344-350
114. Gorsky R.D., Pamuk E., Williamson D.F., Shaffer P.A., Koplan J.P. The 25 year health care costs of women who remain overweight after 40 years of age. Am J Prevent Med. 12:(5):1996;388-394
115. Spielman A.B., Kanders B., Kienholz M., Blackburn G.L. The cost of losing: an analysis of commercial weight loss programs in a metropolitan area. J Am Coll Nutr. 11:(1):1992;36-43
116. Lavery M.A., Loewy J.W. Identifying predictive variables for long term weight change after participation in a weight loss program. J Am Diet Assoc. 93:(9):1993;1017-1024
117. Epstein L.H., Valoski A., Wing R.R., McCurley M.A. Ten-year follow-up of behavorial, family based treatment for obese children. JAMA. 264:1990;2519-2523
118. Kral J.G. Surgical treatment of obesity. Med Clin North Am. 73:(1):1989;251-264